Abstract
The CardioWest temporary total artificial heart (TAH-t; SynCardia, Inc, Tucson, AZ) has been approved and successfully implemented as a temporary device for bridge to cardiac transplantation. After hospitalization and convalescence in a reahilitation center, patients with CardioWest-t in Europe may be discharged from hospital to a home setting, while waiting for a donor organ. We present our single-center experience with outpatient management and follow-up of CardioWest-t recipients.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
